Company Achillion Pharmaceuticals, Inc.
Equities
US00448Q2012
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Director/Board Member | 52 | 20-01-27 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 52 | 20-01-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 140,046,647 | 139,814,104 ( 99.83 %) | 0 | 99.83 % |
Company contact information
Achillion Pharmaceuticals, Inc.
1777 Sentry Parkway West Building 14, Suite 200
19422, Blue Bell
+215-709-3040
http://www.achillion.com![address Achillion Pharmaceuticals, Inc.](https://cdn.zonebourse.com/static/address/35614.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |